Advertisement

Transplantation

  • Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations
    Charline Miot, Kohsuke Imai, Chihaya Imai, Anthony J. Mancini, Zeynep Yesim Kucuk, Tokomki Kawai, Ryuta Nishikomori, Etsuro Ito, Isabelle Pellier, Sophie Dupuis Girod, Jeremie Rosain, Shinya Sasaki, Shanmuganathan Chandrakasan, Jana Pachlopnik Schmid, Tsubasa Okano, Estelle Colin, Alberto Olaya-Vargas, Marco Yamazaki-Nakashimada, Waseem Qasim, Sara Espinosa Padilla, Andrea Jones, Alfons Krol, Nyree Cole, Stephen Jolles, Jack Bleesing, Thomas Vraetz, Andrew R. Gennery, Mario Abinun, Tayfun Güngör, Beatriz Costa-Carvalho, Antonio Condino-Neto, Paul Veys, Steven M. Holland, Gulbu Uzel, Despina Moshous, Benedicte Neven, Stéphane Blanche, Stephan Ehl, Rainer Döffinger, Smita Y. Patel, Anne Puel, Jacinta Bustamante, Erwin W. Gelfand, Jean-Laurent Casanova, Jordan S. Orange and Capucine Picard
  • Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial
    Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner and Peter Dreger
  • Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
    David Miklos, Corey S. Cutler, Mukta Arora, Edmund K. Waller, Madan Jagasia, Iskra Pusic, Mary E. Flowers, Aaron C. Logan, Ryotaro Nakamura, Bruce R. Blazar, Yunfeng Li, Stephen Chang, Indu Lal, Jason Dubovsky, Danelle F. James, Lori Styles and Samantha Jaglowski
  • Hematologic relapse in AL amyloidosis after high-dose melphalan and stem cell transplantation
    Sabrina Browning, Karen Quillen, J. Mark Sloan, Gheorghe Doros, Shayna Sarosiek and Vaishali Sanchorawala
  • How I monitor long-term and late effects after blood or marrow transplantation
    Smita Bhatia, Saro H. Armenian and Wendy Landier
  • Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD
    Nicholas J. Gloude, Pooja Khandelwal, Nathan Luebbering, Dana T. Lounder, Sonata Jodele, Matthew N. Alder, Adam Lane, Alyss Wilkey, Kelly E. Lake, Bridget Litts and Stella M. Davies
  • A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT
    Müberra Ahci, Cristina Toffalori, Evelien Bouwmans, Pietro Crivello, Chiara Brambati, Cinzia Pultrone, Karin Stempelmann, Douglas Bost, Benedetta Mazzi, Dietrich W. Beelen, Fabio Ciceri, Wietse Mulder, Katharina Fleischhauer and Luca Vago
  • Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States
    Lori Muffly, Marcelo C. Pasquini, Michael Martens, Ruta Brazauskas, Xiaochun Zhu, Kehinde Adekola, Mahmoud Aljurf, Karen K. Ballen, Ashish Bajel, Frederic Baron, Minoo Battiwalla, Amer Beitinjaneh, Jean-Yves Cahn, Mathew Carabasi, Yi-Bin Chen, Saurabh Chhabra, Stefan Ciurea, Edward Copelan, Anita D’Souza, John Edwards, James Foran, Cesar O. Freytes, Henry C. Fung, Robert Peter Gale, Sergio Giralt, Shahrukh K. Hashmi, Gerhard C. Hildebrandt, Vincent Ho, Ann Jakubowski, Hillard Lazarus, Marlise R. Luskin, Rodrigo Martino, Richard Maziarz, Philip McCarthy, Taiga Nishihori, Rebecca Olin, Richard F. Olsson, Attaphol Pawarode, Edward Peres, Andrew R. Rezvani, David Rizzieri, Bipin N. Savani, Harry C. Schouten, Mitchell Sabloff, Matthew Seftel, Sachiko Seo, Mohamed L. Sorror, Jeff Szer, Baldeep M. Wirk, William A. Wood and Andrew Artz
  • HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities
    Katharina Fleischhauer and Bronwen E. Shaw
  • Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia
    Paul A. Carpenter, Laura Johnston, Hugo F. Fernandez, Jerald P. Radich, Michael J. Mauro, Mary E. D. Flowers, Paul J. Martin and Theodore A. Gooley

Pages